← Open Payments lookup

CINDY DEREQUITO: Open Payments

NPI 1134745185 · HOLLYWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,819 in 231 payments from 21 companies in 2025. Trend: 2023 $3,802 · 2024 $4,054 · 2025 $4,819

Food & beverage: $4,819
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.22$614
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)23$483
Janssen Pharmaceuticals, Inc18$406
Otsuka America Pharmaceutical, Inc.16$391
ABBVIE INC.21$386
Vanda Pharmaceuticals Inc.11$317
Takeda Pharmaceuticals U.S.A., Inc.16$315
Teva Pharmaceuticals USA, Inc.27$312
Bausch Health US, LLC13$292
Alkermes, Inc.14$280

Products named: INGREZZA, CAPLYTA, REXULTI, VRAYLAR, TRINTELLIX, HETLIOZ, APLENZIN, ARISTADA.

Industry payments across FL — which companies pay providers there.